# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-19-001727
Filing Date
2019-03-14
Accepted
2019-03-14 16:10:28
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | f10k_031219p.htm | 10-K | 1105844
2 | EXHIBIT 21 | exh_21.htm | EX-21 | 1924
3 | EXHIBIT 23 | exh_23.htm | EX-23 | 4520
4 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 6803
5 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 6817
6 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 4007
7 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 4082
14 | GRAPHIC | graph.jpg | GRAPHIC | 28849
| Complete submission text file | 0001171843-19-001727.txt |  | 6575803

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE FILE | bcrx-20181231.xml | EX-101.INS | 1267354
9 | XBRL SCHEMA FILE | bcrx-20181231.xsd | EX-101.SCH | 74258
10 | XBRL CALCULATION FILE | bcrx-20181231_cal.xml | EX-101.CAL | 56067
11 | XBRL DEFINITION FILE | bcrx-20181231_def.xml | EX-101.DEF | 533174
12 | XBRL LABEL FILE | bcrx-20181231_lab.xml | EX-101.LAB | 462448
13 | XBRL PRESENTATION FILE | bcrx-20181231_pre.xml | EX-101.PRE | 556629

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 19681163
SIC: 2836 Biological Products, (No Diagnostic Substances)